Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation

BACKGROUND: Allogeneic bone marrow transplantation (allo-BMT) is a potentially curative therapy for a variety of hematologic diseases, but benefits, including graft-versus-tumor (GVT) activity are limited by graft-versus-host-disease (GVHD). Carcinoembryonic antigen related cell adhesion molecule 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Sydney X., Kappel, Lucy W., Charbonneau-Allard, Anne-Marie, Atallah, Renée, Holland, Amanda M., Turbide, Claire, Hubbard, Vanessa M., Rotolo, Jimmy A., Smith, Marsinay, Suh, David, King, Christopher, Rao, Uttam K., Yim, Nury, Bautista, Johanne L., Jenq, Robert R., Penack, Olaf, Na, Il-Kang, Liu, Chen, Murphy, George, Alpdogan, Onder, Blumberg, Richard S., Macian, Fernando, Holmes, Kathryn V., Beauchemin, Nicole, van den Brink, Marcel R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130781/
https://www.ncbi.nlm.nih.gov/pubmed/21760897
http://dx.doi.org/10.1371/journal.pone.0021611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130781/
https://www.ncbi.nlm.nih.gov/pubmed/21760897
http://dx.doi.org/10.1371/journal.pone.0021611

Ejemplares similares